US Patent 10946097 Fractionated radiotherapy and chemotherapy with an oxygen therapeutic
Patent 10946097 was granted and assigned to NuvOx Pharma on March, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 3 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+168 characters)
Article
Patent abstract
A fluorocarbon emulsion in water for use in fractionated radiotherapy and chemotherapy, wherein said fluorocarbon comprises between 4 and 8 carbon atoms.
Edits on 9 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Evan C. Unger0
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 27 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
109460970
Date of Patent
March 16, 2021
0Patent Application Number
165501830
Date Filed
August 24, 2019
0Official Website
Patent Citations
Patent Citations Received
Patent Primary Examiner
Edits on 28 Dec, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 26 Sep, 2022
Golden AI
Infobox
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 10 Feb, 2022
Golden AI
Edits made to:
Infobox (+10 properties)
US Patent 10946097 Fractionated radiotherapy and chemotherapy with an oxygen therapeutic
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10946097
Date of patent
March 16, 2021
Patent application number
16550183
Date Filed
August 24, 2019
Patent citations
Patent primary examiner
Find more entities like US Patent 10946097 Fractionated radiotherapy and chemotherapy with an oxygen therapeutic
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.